U.S. markets close in 4 hours 4 minutes

Vaso Corporation (VASO)

Other OTC - Other OTC Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
0.2600+0.0031 (+1.21%)
A partir del 11:20AM EDT. Mercado abierto.

Vaso Corporation

137 Commercial Street
Unit 200
Plainview, NY 11803
United States
516 997 4600
https://vasocorporation.com

Sector(es)
Industria
Empleados a tiempo completo300

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Dr. Jun Ma Ph.D.President, CEO & Director921.61kN/D1963
Mr. Jonathan P. NewtonCo-CFO & Treasurer368.78kN/D1961
Mr. Michael J. Beecher CPA, CPACo-CFO & Secretary149.57kN/D1945
Mr. Peter C. CastleChief Operating Officer442kN/D1968
Ms. Jane MoenPresident of VasoHealthcare & Director729.44kN/D1980
Mr. Shen QiumingPresident of Biox Instruments Co LtdN/DN/DN/D
Mr. Randy HillConsultant105kN/D1947
Dr. Derek Enlander M.D.Advisor12kN/D1946
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

Gestión corporativa

La calificación ISS Governance QuickScore de Vaso Corporation a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.